Adalimumab Injection 40 mg. TNF Blocker Biologic Medicine
Advixa 40 (Adalimumab) is a TNF-α inhibitor biologic that reduces inflammation by preventing TNF from binding to its receptors. This targeted immune modulation helps relieve symptoms, limit tissue damage, and improve long-term outcomes in autoimmune conditions.
Indications (Uses) of Adalimumab Injection 40 mg . TNF Blocker Biologic Medicine
-
Rheumatoid Arthritis
-
Juvenile Idiopathic Arthritis
-
Psoriatic Arthritis
-
Adult & Pediatric Crohn’s Disease
-
Ulcerative Colitis
-
Plaque Psoriasis
-
Hidradenitis Suppurativa
Dosage & Administration of Adalimumab Injection 40 mg
-
Route: Subcutaneous injection
-
Strength: 40 mg / 0.8 ml
-
Frequency: As prescribed by a specialist (commonly every other week for many indications)
-
Note: Dosing varies by disease, age, and response.
⚠️ Prescription-only; use under medical supervision.
Storage Conditions
-
Store at 2°C–8°C (refrigerated)
-
Do not freeze
-
Protect from light
-
Keep out of reach of children
Safety & Precautions
-
Patients should be screened for infections (including TB) before starting therapy
-
Increased risk of infections during treatment
-
Regular clinical monitoring is recommended
Frequently Asked Questions (FAQ)
What is Adalimumab Injection 40 mg used for?
Advixa 40 is used to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.
Is Adalimumab a steroid?
No. Adalimumab is a biologic monoclonal antibody, not a steroid.
How is Adalimumab administered?
Advixa 40 is given as a subcutaneous injection, usually at scheduled intervals prescribed by a specialist.
Is Adalimumab suitable for long-term use?
Yes, when used under specialist supervision with appropriate monitoring.
Is a prescription required?
Yes. Adalimumab Injection is a prescription-only biologic medicine.
⚠️ Medical Disclaimer
For informational purposes only. Advixa 40 (Adalimumab) must be used only under the guidance of a qualified healthcare professional.
